D144VRC Entrust Escudo
Implantable Cardioverter Defibrillator (ICD)
D144VRC Entrust Escudo
Information

Device Survival Probability

D144VRC_D154VRC_SURV
Loading...










    1 yr 2 yr 3 yr 4 yr 5 yr 6 yr 7 yr 8 yr 9 yr 10 yr 11 yr at 138.0 mo                  
% Excluding Normal Battery Depletion 99.9 99.9 99.8 99.7 99.4 99.1 98.8 98.7 98.7 98.4 97.9 97.7                  
% Including Normal Battery Depletion 99.6 99.2 98.9 98.4 97.4 92.1 84.7 76.2 61.8 40.7 21.2 13.9                  
#   12683 11493 10278 9080 8016 7016 6014 5100 3862 2299 860 235                  
  • Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
  • Excluding Normal Battery Depletion – This is the malfunction free survival curve.

Performance Notes For This Model

    • There are no performance notes for this model.
Information

Product Characteristics

Generator Type ICD
NBD Code VVE-VVIR
Max. Delivered Energy 35 J
More
Connector Style Cx Style
Serial Number Prefix PNT
Mass 68 g
Volume 35 cc
Waveform Biphasic
X-Ray ID PNT
Hide this content
Cx Style
Information

Estimated Longevity

Charging Frequency 100% Pacing 50% Pacing 15% Pacing 100% Sensing
Monthly 4.8 5.0 5.2 5.3
Quarterly 7.5 8.3 8.8 9.0
Semi-annual 9.0 10.0 10.7 11.0
Footnote

Longevity estimates based on the following device usage. Pacing Mode VVI; Ventricular Lower Pacing Rate 60ppm; Ventricular Pulse Width 0.4ms; Ventricular Pulse Amplitude 3V; Ventricle Impedance 510ohms; Ventricle Sensing Rate 70bpm; EGM prestorage OFF; Optivol ON; Charging frequency assumes maximum energy charge and includes therapy shocks and capacitor formation. Hide this content

Information

Distribution Data

US Market Release
CE Approval Date2008-06-05
Registered USA Implants
Estimated Active USA Implants
Normal Battery Depletions
US Market Release
CE Approval Date2008-06-05
Estimated WW Distribution5040
Normal Battery Depletions9
Information

Malfunctions (USA)

Therapy Function Not Compromised
Therapy Function Compromised
Information

Malfunctions (WW)

Therapy Function Not Compromised 7
Battery 1
Electrical Component 3
Possible Early Battery Depletion 2
Other 1
Therapy Function Compromised 2
Battery 1
Electrical Component 1
Information

EOL Indication

EOL device status is defined as three months following an ERI indication assuming the following post-ERI conditions: 100% VVI pacing at 60 min-1, 2.5 V, 0.4 ms; 500 Ohm pacing load; and six full-energy charges. EOL may be indicated before the end of three months if the device exceeds these conditions.

Information

Elective Replacement (ERI)

Battery voltage less than or equal to 2.61 V on three consecutive daily automatic measurements.

Information

Charge Time

D144VRC_D154VRC_CHRG
Loading...

Data as of January 31, 2018

www.medtronic.com/productperformance 601051